TNF and neoplasm: The APU-R848-IONP platform reprogrammed tumor-associated macrophages by coupling R848-driven and IONP-mediated regulation, reducing the M2/M1 macrophage ratio by 51% and elevating tumoricidal cytokines (TNF-α, IL-12).